ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
35 hedge funds and large institutions have $33.5M invested in Anthera Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding
Funds holding: 33 → 35 (+2)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
35
Holding in Top 10
–
Calls
$147K
Puts
$49K
Top Buyers
| 1 | +$4.59M | |
| 2 | +$742K | |
| 3 | +$409K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$309K |
| 5 |
PA
Perceptive Advisors
New York
|
+$157K |
Top Sellers
| 1 | -$3.44M | |
| 2 | -$614K | |
| 3 | -$223K | |
| 4 |
JG
Jefferies Group
New York
|
-$168K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$99.2K |